Literature DB >> 10209258

Mitosis enhances transgene expression of plasmid delivered by cationic liposomes.

W C Tseng1, F R Haselton, T D Giorgio.   

Abstract

A critical requirement of gene therapy is expression of the delivered transgene. Transgene expression is facilitated by access to the transcription mechanism found primarily in the nucleus. Factors modulating the interactions between intracellular plasmid and nuclear access are not well understood. In this study, the effect of mitosis on transgene expression was examined by quantitative flow cytometry. Transfection of HeLa cells synchronized at late G1 phase or G2/M phase was performed using a liposomal vector containing 1,2-dioleoyl-3-trimethylammonium-propane (DOTAP) and dioleoyl-phosphatidylethanolamine (DOPE) (1:1 mol/mol). Cell samples were transfected and subsequently maintained in G1 phase for various durations to modulate the time between plasmid entry and mitosis. The plasmid contains the sequence for a mutated green fluorescent protein (GFP(S65T)) that was used to examine transgene expression. Ethidium monoazide-labeled plasmid was employed to examine the association of plasmid with the cell membrane. The percentage of cells expressing GFP(S65T) increased sharply as the synchronized cell population passed through M phase, suggesting that an event associated with mitosis is essential for transgene expression. Expression levels of the transgene then declined 18 h after mitosis irrespective of transfection strategy. All transfection strategies resulted in the same maximum percentage of GFP(S65T) positive cells (40%) and average GFP(S65T) expression level (3.14x106 molecules per positive cell). Association of plasmid with the cell membrane at late G1 phase was 1.5-fold of that at G2/M phase. These data are evidence for control of transgene expression triggered by events associated with cell cycle.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10209258     DOI: 10.1016/s0167-4781(99)00039-1

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  35 in total

1.  Novel nuclear shuttle peptide to increase transfection efficiency in esophageal mucosal cells.

Authors:  Colman K Byrnes; Petra H Nass; Joon Shim; Mark D Duncan; Brian Lacy; John W Harmon
Journal:  J Gastrointest Surg       Date:  2002 Jan-Feb       Impact factor: 3.452

Review 2.  Improvement of DNA transfection with cationic liposomes.

Authors:  A Rocha; S Ruiz; J M Coll
Journal:  J Physiol Biochem       Date:  2002-03       Impact factor: 4.158

3.  Environmental parameters influence non-viral transfection of human mesenchymal stem cells for tissue engineering applications.

Authors:  William J King; Nicholas A Kouris; Siyoung Choi; Brenda M Ogle; William L Murphy
Journal:  Cell Tissue Res       Date:  2012-01-26       Impact factor: 5.249

4.  Plasmid delivery in vivo from porous tissue-engineering scaffolds: transgene expression and cellular transfection.

Authors:  Jae-Hyung Jang; Christopher B Rives; Lonnie D Shea
Journal:  Mol Ther       Date:  2005-09       Impact factor: 11.454

5.  Postmitotic nuclear retention of episomal plasmids is altered by DNA labeling and detection methods.

Authors:  Joshua Z Gasiorowski; David A Dean
Journal:  Mol Ther       Date:  2005-09       Impact factor: 11.454

Review 6.  Intracellular trafficking of plasmids for gene therapy: mechanisms of cytoplasmic movement and nuclear import.

Authors:  Erin E Vaughan; James V DeGiulio; David A Dean
Journal:  Curr Gene Ther       Date:  2006-12       Impact factor: 4.391

7.  Multiple and time-scheduled in situ DNA delivery mediated by beta-cyclodextrin embedded in a polyelectrolyte multilayer.

Authors:  N Jessel; M Oulad-Abdelghani; F Meyer; P Lavalle; Y Haîkel; P Schaaf; J-C Voegel
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-30       Impact factor: 11.205

Review 8.  Matrices and scaffolds for DNA delivery in tissue engineering.

Authors:  Laura De Laporte; Lonnie D Shea
Journal:  Adv Drug Deliv Rev       Date:  2007-04-14       Impact factor: 15.470

9.  Local gene delivery from ECM-coated poly(lactide-co-glycolide) multiple channel bridges after spinal cord injury.

Authors:  Laura De Laporte; Anna Lei Yan; Lonnie D Shea
Journal:  Biomaterials       Date:  2009-01-13       Impact factor: 12.479

10.  Polyplex exposure inhibits cell cycle, increases inflammatory response, and can cause protein expression without cell division.

Authors:  Rebecca L Matz; Blake Erickson; Sriram Vaidyanathan; Jolanta F Kukowska-Latallo; James R Baker; Bradford G Orr; Mark M Banaszak Holl
Journal:  Mol Pharm       Date:  2013-03-21       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.